Abstract
Malignancy, cardiovascular events, and infections are the leading causes of death among kidney transplant (KT) recipients. The risk of cancer in KT recipient is two to 4 folds increased than general population with reported higher mortality rates. Post-transplant malignancies can be related to de novo development, donor-related transmission, and recurrence of a recipient’s pre-transplant malignancy. Common malignancies post kidney transplantation are non-melanotic skin cancer, Kaposi sarcoma, post-transplant lymphoproliferative disorder (PTLD), renal cell carcinoma (RCC), and anogenital cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
